We serve Chemical Name:Glaucocalyxin B CAS:80508-81-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Glaucocalyxin B
CAS.NO:80508-81-2
Synonyms:14beta-Acetoxy-7alpha-hydroxy-ent-kaur-16-ene-3,15-dione;Wangzaozin C;(5β,7α,9β,10α,14S)-7-Hydroxy-3,15-dioxokaur-16-en-14-yl acetate
Molecular Formula:C22H30O5
Molecular Weight:374.471
HS Code:
Physical and Chemical Properties:
Melting point:190.5-191 ºC
Boiling point:509.1±50.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.554
PSA:80.67000
Exact Mass:374.209320
LogP:1.37
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 14beta-Acetoxy-7alpha-hydroxy-ent-kaur-16-ene-3,15-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5β,7α,9β,10α,14S)-7-Hydroxy-3,15-dioxokaur-16-en-14-yl acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Wangzaozin C Use and application,14beta-Acetoxy-7alpha-hydroxy-ent-kaur-16-ene-3,15-dione technical grade,usp/ep/jp grade.
Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. Glaucocalyxin B manufacturer FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. Glaucocalyxin B supplier As far as chemical raw materials are concerned, China occupies a large share in the field of bulk raw materials and has become one of the world’s largest suppliers of chemical raw materials. Glaucocalyxin B vendor Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections. Glaucocalyxin B factory There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.
